• Amirimani B, Ning B, Deitz AC, Weber BL, Kadlubar F, Rebbeck TR. 2003. Transcriptional activity effects of a CYP3A4 promoter variant. Environmental and Molecular Mutagenesis 42(4):299305.
  • Benjamini Y & Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Ser. B 57: 289300.
  • Bunin GR, Baumgarten M, Norman SA, Strom BL, Berlin JA. 2005. Practical aspects of sharing controls between case-control studies. Pharmacoepidemiology and Drug Safty 14(8):52330.
  • Davis DL & Sieber SM. 1997. Hormones, hormone metabolism, environment, and breast cancer: a workshop of the National Action Plan on Breast Cancer's Etiology Working Group. Environmenal Health Perspectives 105(Suppl 3): 557.
  • De Vivo I, Guggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA, Hunter DJ. 2002. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci U S A. 99(19):122638.
  • Dinu V, Zhao H, Miller PL. 2007. Integrating domain knowledge with statistical and data mining methods for high-density genomic SNP disease association analysis. Journal of Biomedical Informatics 40(6): 750760.
  • Durrant C, Zondervan KT, Cardon LR, Hunt S, Deloukas P, Morris AP. 2004. Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes. American Journal of Human Genetics 75(1):3543.
  • Easton DF. 1999. How many more breast cancer predisposition genes are there Breast Cancer Research 1(1): 1417.
  • Efron B. 2004. Large-scale simultaneous hypothesis testing: the choice of a null hypothesis. Journal of American Statistical Association 99: 96104.
  • Ford D, Easton DF, Stratton M Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg Y, Hamann U, Haites A, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman A, Breast Cancer Linkage Consortium. 1998. Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families. The American Journal of Human Genetics 62(3), 676689.
  • Hoeffding W. 1948. A class of statistics with asymptotically normal distribution. Annals of Mathematical Statistics 22:165179.
  • Kadlubar FF, Berkowitz GS, Delongchamp RR, Wang C, Green BL, Tang G, Lamba J, Schuetz E, Wolff MS. 2003. The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer. Cancer Epidemiology, Biomarkers & Prevention 12(4): 32731.
  • Kwee LC, Liu D, Lin X, Ghosh D, Epstein MP. 2008. A powerful and flexible multilocus association test for quantitative traits. American Journal of Human Genetics 82(2):38697.
  • Lambert JC & Amouyel P. 2007. Genetic heterogeneity of Alzheimer's disease: complexity and advances. Psychoneuroendocrinology, Suppl 1:S6270.
  • Longmate JA. 2001. Complexity and power in case-control association studies. American Journal of Human Genetics 68:12291237
  • Neale B & Sham P. 2004. The future of association studies: gene-based analysis and replication. American Journal of Human Genetics 75: 353362.
  • Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM. 1997. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochemistry and Biophysics Research Communication 239(1):298304.
  • Rebbeck TR, Troxel AB, Wang Y, Walker AH, Panossian, S, Gallagher S, Shatalova EG, Blanchard R, Norman S, Bunin G, DeMichele A, Rubin SC, Baumgarten M, Berlin M, Schinnar R, Berlin JA, Strom BL. 2006. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. Journal of the National Cancer Institute 98(18):13111320.
  • Schaid DJ, McDonnell SK, Hebbring SJ, Cunningham JM, Thibodeau SN. 2005. Nonparametric tests of association of multiple genes with human disease. American Journal of Human Genetics 76(5):78093.
  • Sen PK. 2006. Robust statistical inference for high-dimensional data models with application to genomics. Austrian Journal of Statistics and Probability 35: 197214.
  • Slager SL, Huang J, Vieland VJ. 2000. Effect of allelic heterogeneity on the power of the transmission disequilibrium test. Genetic Epidemiology 18:143156
  • Strom BL, Schinnar R, Weber AL, Bunin GR, Berlin JA, Baumgarten M, DeMichele AM, Rubin SC, Berlin M, Troxel AB, Rebbeck TR. 2006. Protective effect of postmenopausal use of combined estrogen plus progestin hormone therapy on endometrial cancer risk. American Journal of Epidemiology 164(8):775.
  • Wang K, Li M, Bucan M (2007): Pathway-based approaches for analysis of genomewide association studies. American Journal of Human Genetics 81(6): 12781283.
  • Wei LJ & Johnson WE. 1985. Combining dependent tests with incomplete repeated measurements. Biometrika 72:359364.
  • Wei Z & Li H. 2007. Nonparametric pathway-based regression models for analysis of genomic data. Biostatistics 8(2):265284.
  • Yager JD & Liehr JG. 1996. Molecular mechanisms of estrogen carcinogenesis. Annual Review of Pharmacology and Toxicology 36: 20332.
  • Zondervan KT & Cardon LR. 2004. The complex interplay among factors that influence allelic association. Nature Review Genetics 5:89100